Other Business News -Optical Coherence Tomography News

Articles in category: Other Business News

985-1008 of 1221 « 1 2 ... 39 40 41 42 43 44 45 ... 49 50 51 »
1. Lightlab Imaging Wins Prism Award for Innovation with its Frequency-Domain Cardiovascular OCT Imaging System
  
  Explore Photonics.com Jan 28 2010 Cardiology , Other Business News
  
  LightLab Imaging Inc. for its C7-XR Optical Coherence Tomography System. LightLab's C7-XR frequency-domain system employs advanced photonics technologies to provide cardiologists with an interior view of coronary arteries. Its ultrafast imaging speed, micron-scale resolution and 3-D visualization capabilities streamline the clinician's work flow and redefine the possibilities of interventional cardiology imaging. The awards, co-sponsored by Laurin Publishing and SPIE, were presented during a gala ceremony held during SPIE Photonics West at the Hilton San Francisco and attended by approximately 400 leaders of the photonics industry. The Prism Awards honor photonics innovation. Judges from SPIE and the advisory board ...
  Read Full Article
  
  Comment
  
  Mentions: Abbot
2. LightLab Imaging Receives Prism Award
  
  Explore Optical Coherence Tomography News Jan 27 2010 Cardiology , Other Business News
  
  Westford, MA, January 27, 2010 – LightLab Imaging Inc., the pioneer and leader in the development of Optical Coherence Tomography (OCT) for vascular and other imaging applications, today announced the receipt of the Prism Award for Photonics Innovation in the life sciences category. This award was presented by Laurin Publishing and SPIE during SPIE Photonics West on January 27, 2010 to honor photonics innovation. Awards were presented to nine other products in eight other categories. “It is an honor to be recognized by SPIE with this Prism Award.” said Joe Schmitt, Chief Technology Officer of LightLab Imaging. “This shows how the ...
  Read Full Article
  
  Comment
  
  Mentions: Joseph M. Schmitt Abbot David W. Kolstad
3. Volcano (VOLC) Guides FY10 Revs Above Street; Sees $280M vs. $276.85M Consensus
  
  Explore StreetInsider.com Jan 26 2010 Cardiology , Other Business News
  
  As disclosed in an article published in the San Diego Union-Tribune on January 25, 2010, Volcano Corporation (NASDAQ: VOLC) projects approximately $280 million in revenues for the fiscal year ending December 31, 2010. Consensus sees revs of $276.85 million. The Company’s fourth quarter and full-year 2009 operating and financial performance and updated guidance for fiscal 2010 will be provided in a press release, as well as in a conference call and webcast, in early March. Details of the earnings release date, conference call and webcast will be provided by the Company in a subsequent release.
  Read Full Article
  
  Comment
  
  Mentions: Volcano Corporation
4. e2v partners with Bayspec to deliver leading OCT spectral engine
  
  Explore e2v.com Jan 22 2010 Other Business News
  
  e2v, the leading designer, developer and manufacturer of CCD and CMOS imaging sensors and cameras, and Bayspec, Inc., a world leader in advanced spectroscopy solutions, have announced that their successful partnership has delivered a new Optical Coherence Tomography (OCT) spectral engine. e2v’s new Aviiva EM4 linescan camera, incorporating an imaging sensor optimised for OCT, enables Bayspec’s DeepView spectrograph to perform at up to three times greater collection efficiency than standard Czerny-Turner spectrographs, while offering a 10 times improvement in the detector sensitivity signal/noise ratio. With a dynamic range of more than 68 dB and a line rate ...
  Read Full Article
  
  Comment
  
  Mentions: e2v BaySpec Inc. Eric Bergles
5. BaySpec partners with e2v on OCT spectral engine
  
  Explore OptoIQ Home Jan 22 2010 Other Business News
  
  January 22, 2010--BaySpec (Fremont, CA), manufacturer of advanced spectroscopy solutions, is pleased to announce the successful outcome of a collaboration with e2v (Chelmsford, England) on a new optical coherence tomography (OCT) spectral engine that allows up to three times greater collection efficiency than standard Czerny-Turner spectrographs, while offering a 10x signal-to-noise ratio improvement in detector sensitivity. BaySpec’s DeepView Spectrograph, designed for the expanding spectral domain-optical coherence tomography (SD-OCT) market, provides high throughput spectral measurements in an ultra compact package and factory calibrated for long-life and low-cost of ownership. Based around e2v’s family of SD-OCT Aviiva EM4 detector array ...
  Read Full Article
  
  Comment
  
  Mentions: e2v BaySpec Inc. Eric Bergles
6. BaySpec OCT spectral engine at Photonics West
  
  Explore Home: SPIE.org Jan 22 2010 Other Business News
  
  BaySpec, Inc., a world leader in advanced spectroscopy solutions, is pleased to announce the successful outcome of a collaboration on a new OCT spectral engine that allows up to three times greater collection efficiency than standard Czerny-Turner spectrographs, while offering 10x the signal/noise ratio improvement in detector sensitivity. BaySpec will be exhibiting at SPIE Photonics. BaySpec's DeepView Spectrograph, designed for the expanding spectral domain-optical coherence tomography (SD-OCT) market, provides high throughput spectral measurements in an ultra compact package and factory calibrated for long-life and low-cost of ownership.
  Read Full Article
  
  Comment
  
  Mentions: e2v BaySpec Inc. Eric Bergles
7. Volcano Corporation Product Pipeline Analysis
  
  Explore prminds.com Jan 18 2010 Cardiology , Other Business News
  
  This report is an insightful source for data, analysis and strategic insights into a Volcano Corporation’s pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.
  Read Full Article
  
  Comment
  
  Mentions: Volcano Corporation
8. Governor of Massachusetts Deval Patrick sees the Light(Lab)
  
  Explore Home - Lowell Sun Online Jan 13 2010 Cardiology , Other Business News
  
  WESTFORD -- By his own admission, Gov. Deval Patrick didn't comprehend much of what he was being shown during his tour of the LightLab Imaging facility in Westford yesterday. But Patrick did understand, and was able to emphasize, the importance of life-science companies prospering throughout the state. "It's wonderful to hear about the way the company has grown organically with Massachusetts talent, with Massachusetts people and Massachusetts ideas and inventions, and how that growth continues," Patrick told more than half of the company's 100 employees at the end of the tour. "We are very proud that through the ...
  Read Full Article
  
  Comment
  
  Mentions: Abbot David W. Kolstad Warren Clark
9. Michelson Diagnostics VivoSight OCT Scanner Receives FDA 510(k) Clearance
  
  Explore GlobeNewswire, Inc. Jan 12 2010 Other Business News
  
  ORPINGTON, United Kingdom, Jan. 12, 2010 (GLOBE NEWSWIRE) -- Michelson Diagnostics Ltd, the London, UK based developer and manufacturer of Optical Coherence Tomography (OCT) products, announced today that the US Food & Drug Administration (FDA) has awarded it 510(k) clearance for its VivoSight(TM) OCT scanning product. For clinical use, FDA 510(k) K093520 applies: "VivoSight(TM) is a Multi-Beam Optical Coherence Tomography (OCT) system indicated for use in the two-dimensional, cross-sectional, real-time imaging of external tissues of the human body." VivoSight(TM) is the first Fourier-Domain OCT scanner to receive FDA 510(k) clearance, outside of the field of ophthalmology ...
  Read Full Article
  
  Comment
  
  Mentions: Michelson Diagnostics Jon Holmes FDA
10. Volcano Corporation Announces Preliminary Record Revenues for Fourth Quarter 2009; Total Year Revenues are Expected to Exceed Prior Guidance
  
  Explore PR Newswire Jan 11 2010 Cardiology , Other Business News
  
  SAN DIEGO, Jan 11 /PRNewswire-FirstCall/ -- Volcano Corporation (Nasdaq: VOLC), a leader in the development, manufacture and sales of products for the diagnosis and treatment of coronary and peripheral artery disease, said today that it expects total revenues for fiscal 2009 will be approximately $228.0 million, with revenues in the fourth quarter of fiscal 2009 expected to be approximately $71.0 million. The revenue expectations for fiscal 2009 compare with the company's prior guidance for fiscal 2009 revenues of $218.0-$223.0 million, and reflect year-over-year revenue growth of approximately 33 percent. The expectations for revenues in the ...
  Read Full Article
  
  Comment
  
  Mentions: Scott Huennekens Volcano Corporation
11. Gen Rodrigues Inaugurates GEI Mohali; GEI brings world's finest Eye Care to Mohali
  
  Explore indiaprwire.com Jan 11 2010 Ophthalmology , Other Business News
  
  GEI, the region's leading Eye Care chain, formally announced the launch of its regional eye clinic and surgery centre, GEI Mohali, here today. GEI Mohali, located at the premises of Ivy Hospital, Sector 71, Mohali, was inaugurated by His Excellency Governor of Punjab, Gen. (Retd.) SF Rodrigues. With the launch of GEI Mohali, GEI is bringing its signature premier eye care services at affordable rates to the residents of Mohali.
  Read Full Article
  
  Comment
12. Despite Economic Crisis, OCT Market Grows in 2009, Reaching $315 Million
  
  Explore Optical Coherence Tomography News Jan 5 2010 Other Business News
  
  January 6, 2010—Mountain View, CA—Optical coherence tomography (OCT) is continuing its rapid expansion as a fast, high-resolution imaging tool for clinical diagnostics. Systems sales grew in 2009, despite the economic crisis, with compound annual growth rate of 20% expected through 2014. The market for OCT systems is entering a new phase as it moves beyond ophthalmology and is applied to new medical specialties. These are among the findings in a new report, OCT 2010: Technology, Applications, and Markets, from market research firm Strategies Unlimited, the research unit for PennWell. OCT systems use advanced optical techniques to construct micron-scale ...
  Read Full Article
  
  Comment
  
  Mentions: Carl Zeiss Meditec Gregory Smolka
13. Optical coherence tomography market grows into new phase
  
  Explore BioOptics World Jan 5 2010 Other Business News
  
  JANUARY 5, 2010--"The market for OCT systems is entering a new phase as it moves beyond ophthalmology and is applied to new medical specialties," reports a new market research study by Strategies Unlimited (Mountain View, CA). Titled OCT 2010: Technology, Applications, and Markets, the report says that despite the dismal 2009 economy, sales of optical coherence tomography (OCT) systems grew to $315 million, and a compound annual growth rate of 20% is expected through 2014. The report is an update to the first study ever to quantify the OCT market. OCT systems use advanced optical techniques to construct micron-scale ...
  Read Full Article
  
  Comment
  
  Mentions: Carl Zeiss Meditec Gregory Smolka Barbara G. Goode
14. Michelson Diagnostics Receives New Funding to Accelerate Growth
  
  Explore GlobeNewswire, Inc. Jan 5 2010 Dermatology , Oncology , Funding , Other Business News
  
  ORPINGTON, United Kingdom, Jan. 5, 2010 (GLOBE NEWSWIRE) -- Michelson Diagnostics Ltd, the London, UK based developer and manufacturer of Optical Coherence Tomography (OCT) products, has raised GBP664,000 ($1.1M) to fund the next stage of its growth. The new funding will enable Michelson to enlarge its sales force, perform larger, more comprehensive trials on multiple applications, and to prepare for volume clinical sales. Investors in the funding round included a syndicate of business angels drawn from London Business Angels and Oxford Investment Opportunity Networks, and from existing shareholders including Catapult Venture Managers Ltd and London Seed Capital Ltd. Michelson ...
  Read Full Article
  
  Comment
  
  Mentions: Michelson Diagnostics Jon Holmes
15. Volcano Corporation Announces Receipt Of CE Mark For Its OCT Imaging Mark For Its OCT Imaging System And Catheter
  
  Explore thestreet.com Jan 5 2010 Cardiology , Other Business News
  
  SAN DIEGO, Jan. 5 /PRNewswire-FirstCall/ -- Volcano Corporation (Nasdaq: VOLC), a leader in the development, manufacture and sales of products for the diagnosis and treatment of coronary and peripheral artery disease, announced today receipt of CE mark for their OCT (Optical Coherence Tomography) imaging system and catheter. Volcano's OCT product line is expected to complement its existing line of IVUS imaging catheters and pressure guide wires used for coronary imaging and lesion assessment. "This is an important milestone in our development of OCT and highlights the progress of our OCT program overall," noted Vince Burgess, President of Advanced Imaging Systems ...
  Read Full Article
  
  Comment
  
  Mentions: CardioSpectra Volcano Corporation
16. Volcano Corporation Presentation at J.P. Morgan Conference to be Webcast
  
  Explore news.moneycentral.msn.com Jan 5 2010 Cardiology , Other Business News
  
  Volcano Corporation VOLC a leader in the development, manufacture and sales of products for the diagnosis and treatment of coronary and peripheral artery disease, said today that it will be participating in the 28th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12. The presentation by Scott Huennekens, president and chief executive officer, will begin at 2 p.m., Pacific Standard Time, (5 p.m., Eastern Standard Time).
  Read Full Article
  
  Comment
  
  Mentions: Scott Huennekens Volcano Corporation
17. Volcano Corp. (VOLC) President & Ceo R Scott Huennekens sells 17,500 Shares
  
  Explore GuruFocus Jan 4 2010 Cardiology , Other Business News
  
  VOLCANO CORPORATION designs, develops, manufactures, and commercializes a range of intravascular ultrasound and functional measurement products for the diagnosis and treatment of vascular and structural heart disease worldwide. The company's IVUS products consist of consoles, single-procedure disposable catheters, and various functionality options. Its FM devices measure the pressure and flow characteristics of blood around plaque thereby allowing physicians to gauge the plaque's impact on blood flow and pressure. The FM products consist of pressure and flow consoles and single-procedure disposable pressure and flow guide wires. It markets IVUS consoles as stand-alone units or customized units that can be ...
  Read Full Article
  
  Comment
  
  Mentions: Scott Huennekens Volcano Corporation
18. Massachusetts awards $25M in tax incentives to life sciences firms including Lightlab Imaging
  
  Explore masshightech.com Dec 24 2009 Cardiology , Funding , Other Business News
  
  The board of directors of the Massachusetts Life Sciences Center has awarded 28 life sciences companies a total of $25 million in tax incentives. The companies have agreed to create 918 jobs in the next year.
  Read Full Article
  
  Comment
  
  Mentions: Abbot
19. Massachusetts hands out $25 million in life science tax breaks
  
  Explore Boston.com Dec 23 2009 Funding , Other Business News
  
  he board of the Massachusetts Life Sciences Center awarded $25 million in tax incentives to 28 life sciences companies that commited to creating a total of 918 new jobs in the coming year. The tax breaks were established under the Patrick administration's 10-year, $1 billion life sciences initiative. A mix of large companies and start-ups in the biotechnology and medical device industries received the incentives. They include: Anylum Pharmaceuticals Inc. of Cambridge, Biogen Idec Inc. of Cambridge, Constellation Pharmaceuticals Inc. of Cambridge, Cubist Pharmaceuticals Inc. of Lexington, Dyax Corp. of Cambridge, Facet Solutions of Hopkinton, FoldRx Pharmaceuticals Inc. of ...
  Read Full Article
  
  Comment
  
  Mentions: Abbot InfraReDx
20. Volcano lauds revised guidelines for treating severe coronary artery disease patients
  
  Explore MEDICAL NEWS Dec 23 2009 Cardiology , Other Business News
  
  Volcano Corporation (Nasdaq: VOLC), a leader in the development, manufacturing and sales of products for the diagnosis and treatment of coronary and peripheral artery disease, reacted positively to the new guidelines for treating coronary disease and heart attacks using percutaneous coronary intervention (PCI), a procedure that treats narrowed blood vessels. Based on the strength of the latest clinical data supporting the usage of Fractional Flow Reserve (FFR), the American Heart Association (AHA), the American College of Cardiology (ACC), and the Society for Cardiovascular Angiography and Interventions (SCAI) elevated the level of evidence for FFR in their guidelines from Level B ...
  Read Full Article
  
  Comment
  
  Mentions: Scott Huennekens Volcano Corporation University of North Carolina
21. Volcano Corporation Commends the Elevation of FFR to Level of Evidence A in New PCI Guidelines
  
  Explore Yahoo! Finance Dec 22 2009 Cardiology , Other Business News
  
  Volcano Corporation , a leader in the development, manufacturing and sales of products for the diagnosis and treatment of coronary and peripheral artery disease, reacted positively to the new guidelines for treating coronary disease and heart attacks using percutaneous coronary intervention , a procedure that treats narrowed blood vessels.
  Read Full Article
  
  Comment
  
  Mentions: Volcano Corporation American Heart Association
22. Volcano Announces Installed Base Growth Milestone
  
  Explore money.cnn.com Dec 15 2009 Cardiology , Other Business News
  
  Placement of Over 2,500 s5 and s5i Multi-Modality Systems Highlights Continued Momentum versus Competition, Growing World-Wide Demand for Access to FFR and IVUS: Volcano Corporation (Nasdaq: VOLC), a leading developer of precision intravascular therapy guidance tools – including Fractional Flow Reserve (FFR), Intravascular Ultrasound (IVUS), Forward Looking IVUS and Optical Coherence Tomography (OCT) – designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, announced today the placement of over 2,500 s5 family consoles worldwide. The s5 family of consoles was first launched in April 2006, with more than 1,000 systems placed in the last 12 ...
  Read Full Article
  
  Comment
  
  Mentions: Axsun Technologies Volcano Corporation FDA
23. Volcano Announces Installed Base Growth Milestone
  
  Explore bio-medicine.org Dec 15 2009 Cardiology , Other Business News
  
  SAN DIEGO, Dec. 15 /- Volcano Corporation (Nasdaq: VOLC ), a leading developer of precision intravascular therapy guidance tools - including Fractional Flow Reserve (FFR), Intravascular Ultrasound (IVUS), Forward Looking IVUS and Optical Coherence Tomography (OCT) - designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, a...
  Read Full Article
  
  Comment
  
  Mentions: Cardiovascular Research Foundation Scott Huennekens
24. ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-related Macular Degeneration (AMD)
  
  Explore PipelineReview.com Dec 12 2009 Ophthalmology , Other Business News
  
  hromboGenics announces that it has started a Phase II trial of microplasmin for the treatment of exudative (wet) Age-related Macular Degeneration (AMD) Leuven, Belgium | December 11, 2009 | ThromboGenics NV (Euronext Brussels: THR), a biopharmaceutical company focused on innovative medicines for eye disease, vascular disease and cancer, announces today that it has started a Phase II trial of microplasmin for the treatment of exudative (wet) Age-related Macular Degeneration (AMD). Wet AMD affects approximately five million patients worldwide and this patient population is continuing to grow. Wet AMD occurs when abnormal blood vessels behind the retina start to grow under the macula ...
  Read Full Article
  
  Comment
985-1008 of 1221 « 1 2 ... 39 40 41 42 43 44 45 ... 49 50 51 »